ZNF684
Zinc finger protein 684
Also known as: MGC27466, ZN684_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5T5D7
- Gene
- ZNF684
- Ensembl
- ENSG00000117010
- Chromosome
- 1
- Canonical length
- 378 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within innate immune response and negative regulation of single stranded viral RNA replication via double stranded DNA intermediate. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
378 residues, UniProt reviewed canonical sequence.
>Q5T5D7|ZNF684
1 MISFQESVTF QDVAVDFTAE EWQLLDCAER TLYWDVMLEN YRNLISVGCP ITKTKVILKV
61 EQGQEPWMVE GANPHESSPE SDYPLVDEPG KHRESKDNFL KSVLLTFNKI LTMERIHHYN
121 MSTSLNPMRK KSYKSFEKCL PPNLDLLKYN RSYTVENAYE CSECGKAFKK KFHFIRHEKN
181 HTRKKPFECN DCGKAYSRKA HLATHQKIHN GERPFVCNDC GKAFMHKAQL VVHQRLHTGE
241 KPYECSQCGK TFTWNSSFNQ HVKSHTLEKS FECKECGKTF RYSSSLYKHS RFHTGEKPYQ
301 CIICGKAFGN TSVLVTHQRI HTGEKPYSCI ECGKAFIKKS HLLRHQITHT GEKPYECNRC
361 GKAFSQKSNL IVHQKIHTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF684 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- liver: 12 nTPM
- heart muscle: 7.2 nTPM
- kidney: 6.4 nTPM
- bone marrow: 6 nTPM
- adrenal gland: 3.6 nTPM
- thyroid gland: 3.6 nTPM
Single-cell type
- renal collecting duct intercalated cells: 36 nCPM
- distal convoluted tubule cells: 35 nCPM
- renal connecting tubule cells: 35 nCPM
- cardiomyocytes: 34 nCPM
- hepatocytes: 33 nCPM
- choroid plexus epithelial cells: 25 nCPM
Immune cell
- basophil: 4.3 nTPM
- intermediate monocyte: 4 nTPM
- memory B-cell: 3.4 nTPM
- gdT-cell: 2.9 nTPM
- naive CD8 T-cell: 2.6 nTPM
- T-reg: 2.5 nTPM
Brain region
- white matter: 11 nTPM
- medulla oblongata: 8.7 nTPM
- basal ganglia: 8.5 nTPM
- choroid plexus: 8.1 nTPM
- thalamus: 8 nTPM
- midbrain: 7.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.48
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.65
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF684 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF684 as an antibody target. Whether an autoantibody or antibody against ZNF684 could matter depends on whether native ZNF684 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF684 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF684 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...